Janney Montgomery Scott LLC Durect Corp Transaction History

Janney Montgomery Scott LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 27, 2022	BUY	$0.9 - $1.31 $10,833 - $15,768	12,037 New	12,037 $12,000
Q3 2021 Oct 29, 2021	SELL	$1.21 - $1.61 $36,300 - $48,300	-30,000 Closed	0 $0
Q2 2021 Jul 26, 2021	SELL	$1.6 - $2.02 $6,400 - $8,080	-4,000 Reduced 11.76%	30,000 $49,000
Q1 2021 Apr 27, 2021	BUY	$1.86 - $2.87 $63,240 - $97,580	34,000 New	34,000 $67,000
Q4 2020 Jan 25, 2021	SELL	$1.65 - $2.43 $20,625 - $30,375	-12,500 Closed	0 $0
Q1 2020 Apr 30, 2020	BUY	$0.97 - $2.85 $485 - $1,425	500 Added 4.17%	12,500 $19,000
Q4 2019 Jan 21, 2020	BUY	$1.69 - $3.8 $20,280 - $45,600	12,000 New	12,000 $46,000

593K

Ticker DRRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 227,794,000
Market Cap $173M
Description
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

Stay updated on Janney Montgomery Scott LLC with notifications on news.